FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
Fiche publication
Date publication
janvier 2018
Journal
PloS one
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie, Pr BRUNOTTE François, Pr FUMOLEAU Pierre, Pr COCHET Alexandre
Tous les auteurs :
Depardon E, Kanoun S, Humbert O, Bertaut A, Riedinger JM, Tal I, Vrigneaud JM, Lasserre M, Toubeau M, Berriolo-Riedinger A, Dygai-Cochet I, Fumoleau P, Brunotte F, Cochet A
Lien Pubmed
Résumé
Evaluate response and predict prognosis of patients with newly diagnosed metastatic breast cancer treated with first line systemic therapy using European Organization for Research and Treatment of Cancer (EORTC) criteria and PET Response Criteria in solid Tumours (PERCIST).
Mots clés
Adult, Aged, Aged, 80 and over, Biomarkers, Tumor, Breast Neoplasms, diagnostic imaging, Female, Fluorodeoxyglucose F18, Follow-Up Studies, Humans, Middle Aged, Neoplasm Grading, Neoplasm Metastasis, Neoplasm Staging, Positron Emission Tomography Computed Tomography, methods, Proportional Hazards Models, Retrospective Studies
Référence
PLoS ONE. 2018 ;13(7):e0199529